See double-digit growth next year if macros improve: Aarti Drugs

Adhish Patil, CFO, Aarti Drugs said the slowdown in sales for the third quarter was mainly due to decline in exports and some inventory losses.However, Patil is confident that some of the product launches will start contributing towards growth in next year and if macro economic conditions improve then the company would surely see double-digit growth. However, for the current year, the growth is unlikely to be more than 5 percent over the previous fiscal.Weak crude oil prices impacted exports, which in turn impacted sales in Q3.The revenues for Q3 was down 1.67 percent at Rs 256.7 crore versus Rs 261.1 crore reported in the same quarter FY15. EBITDA too was down 3.06 percent at Rs 42.4 crore versus Res 43.8 crore, while operating profit margins was flat at 17 percent year-on-year.For the entire discussion, watch video